Equasens

EQUASENS: 2022 Net Profit: +18.35% to €48.70m

24 3月 2023 13:00:00 条件 Nasdaq GlobeNewswire

EQUASENS: FY 2022 revenue: +10.88% to €214.07m

03 2月 2023 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT

20 1月 2023 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS: Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer

19 1月 2023 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS GROUP: 2022 third-quarter revenue

09 11月 2022 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS: subsidiary PANDALAB receives ISO 27001 and HDS certifications

18 10月 2022 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS: H1 2022 Results

22 9月 2022 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue

03 8月 2022 12:00:00 条件 Nasdaq GlobeNewswire

Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions

28 7月 2022 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT

21 7月 2022 12:00:00 条件 Nasdaq GlobeNewswire

EQUASENS (Ex Pharmagest Interactive): RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 28 JUNE 2022

06 7月 2022 13:01:24 条件 Nasdaq GlobeNewswire

EQUASENS (ex Pharmagest Interactive) joins Euronext’s new TECH LEADERS segment

27 6月 2022 01:00:00 条件 Nasdaq GlobeNewswire